A previous report revealed that the depletion of RMP increases CDDP and rapamycin-induced apoptosis in ovarian cancer cells by activating mitochondrial S6K1-BAD signaling pathway, which indicated that RMP might play an important role in the deregulation of apoptotic pathway 32. The gene discussed is RPS6KB1; the disease is ovarian carcinoma.